Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Ohm, Milouvan Straalen, Joeri W
Zijlstra, Marieke
de Joode-Smink, Gerrie
Jasmijn Sellies, Anne
Swart, Joost F
Vastert, Sebastiaan J
van Montfrans, Joris M
Bartels, Marije
van Royen-Kerkhof, Annet
Wildenbeest, Joanne G
Lindemans, Caroline A
Wolters, Victorien
Wennink, Roos A W
de Boer, Joke H
Knol, Mirjam J
Heijstek, Marloes W
Sanders, Elisabeth A M
Verduyn-Lunel, Frans M
Berbers, Guy A M
Wulffraat, Nico M
Jansen, Marc H A
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study.Published in
Vaccine 2023;online ahead of printPMID
37198018ae974a485f413a2113503eed53cd6c53
10.1016/j.vaccine.2023.04.056
Scopus Count
Collections
Related articles
- Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as Toddlers.
- Authors: Nolan T, Booy R, Marshall HS, Richmond P, Nissen M, Ziegler JB, Baine Y, Traskine M, Jastorff A, Van der Wielen M
- Issue date: 2019 Jun
- Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study.
- Authors: Klein NP, Habanec T, Kosina P, Shah NR, Kolhe D, Miller JM, Hezareh M, Van der Wielen M
- Issue date: 2018 Apr 19
- Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.
- Authors: van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Knol MJ, Stoof SP, Sanders EAM, Berbers GAM
- Issue date: 2017 Aug 24
- Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
- Authors: van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM
- Issue date: 2017 Aug 24
- Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
- Authors: Robertson CA, Greenberg DP, Hedrick J, Pichichero M, Decker MD, Saunders M
- Issue date: 2016 Oct 17